BiographyDr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Department of Biostatistics, the Department of GLobal Health and the Department of Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS and the Epidemiology of Tuberculosis. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, Peru, South Africa and Tanzania. He has served as the National Steering Committee Co-Chairman of the Tuberculosis Trials Consortium and the Tuberculosis Epidemiologic Studies Consortium. He is currently the Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials (www.resisttb.org). His office is located in the Center for Global Health and Development at BU School of Public Health.
- Professor of Epidemiology, Epidemiology, Boston University School of Public Health
- Professor, Infectious Diseases, Medicine, Boston University School of Medicine
- Professor, Biostatistics, Boston University School of Public Health
- Boston Medical Center
- Case Western Reserve University, MD
- Yale University, MUS
- Princeton University, AB
- Published on 1/21/2016
Hochberg NS, Rekhtman S, Burns J, Ganley-Leal L, Helbig S, Watts NS, Brandeis GH, Ellner JJ, Horsburgh CR. The complexity of diagnosing latent tuberculosis infection in older adults in long-term care facilities. Int J Infect Dis. 2016 Mar; 44:37-43. PMID: 26802447.
- Published on 12/31/2015
Baranoski AS, Cotton D, Heeren T, Nunes D, Kubiak RW, Horsburgh CR. Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men. Open Forum Infect Dis. 2016 Jan; 3(1):ofv214. PMID: 26955643.
- Published on 11/26/2015
Horsburgh CR, Barry CE, Lange C. Treatment of Tuberculosis. N Engl J Med. 2015 Nov 26; 373(22):2149-60. PMID: 26605929.
- Published on 9/24/2015
Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, Van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J. 2015 Dec; 46(6):1563-76. PMID: 26405286.
- Published on 8/19/2015
Hermans S, Horsburgh CR, Wood R. A Century of Tuberculosis Epidemiology in the Northern and Southern Hemisphere: The Differential Impact of Control Interventions. PLoS One. 2015; 10(8):e0135179. PMID: 26288079.
- Published on 8/15/2015
O'Donnell MR, Pillay M, Pillay M, Werner L, Master I, Wolf A, Mathema B, Coovadia YM, Mlisana K, Horsburgh CR, Padayatchi N. Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2015 Aug 15; 69(5):536-43. PMID: 25886924.
- Published on 7/17/2015
Simonsen DF, Søgaard M, Bozi I, Horsburgh CR, Thomsen RW. Risk factors for postoperative pneumonia after lung cancer surgery and impact of pneumonia on survival. Respir Med. 2015 Oct; 109(10):1340-6. PMID: 26209227.
- Published on 6/9/2015
Ristola M, Arbeit RD, von Reyn CF, Horsburgh CR. Isolation of Mycobacterium avium from Potable Water in Homes and Institutions of Patients with HIV Infection in Finland and the United States. Biomed Res Int. 2015; 2015:713845. PMID: 26180808.
- Published on 2/28/2015
Anderson JP, Horsburgh CR, Williams PL, Tchetgen Tchetgen EJ, Nunes D, Cotton D, Seage GR. CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug users. Open Forum Infect Dis. 2015 Jan; 2(1):ofv019. PMID: 26034769.
- Published on 2/15/2015
Horsburgh CR. Overestimation of coprevalent and underestimation of incident tuberculosis in close contacts. Am J Respir Crit Care Med. 2015 Feb 15; 191(4):486-7. PMID: 25679110.
View 153 more publications:View full profile at BUMC